Preclinical drug research platform and project management for pharmaceutical discovery
益普科技 operates a preclinical research platform focused on pharmacology evaluation, GPCR/nuclear receptor screening, and PK (pharmacokinetics) analysis for early-stage drug development. The hiring profile reveals a research-heavy organization (26 roles in research vs. 8 in engineering) with specialized leadership in electrophysiology and DMPK, indicating they're scaling the bench science side rather than building consumer-facing software — the tech stack (PHP + MySQL + MES/ERP/CRM) reflects operational tooling, not product innovation.
Notable leadership hires: Electrophysiology Lead, DMPK Director, Chief of Staff, Project Lead
益普科技 is a preclinical drug research services company based in Shenzhen, China. The organization provides pharmacology evaluation, drug candidate screening (GPCR and nuclear receptor platforms), and PK experiment design services to pharmaceutical and biotech clients. The company operates a mixed technical and research infrastructure: legacy enterprise software (ERP, MES, CRM) alongside specialized laboratory information systems and project management platforms. Current hiring focus spans research scientists, DMPK specialists, and electrophysiology leads, with active work on GLP compliance audit and preclinical data platform development.
Primary stack: PHP, Nginx, MySQL, Axure RP (UI prototyping), CAD, and UG NX (design software). Operational systems include MES, ERP, CRM. Also uses qPCR and PLC for laboratory automation and control.
Core projects: GPCR and nuclear receptor drug development detection platform, pharmacology evaluation technology platform, preclinical PK experiment design and analysis, GLP compliance audit, and project management system development.
Other companies in the same industry, closest in size